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Abstract
Introduction: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are increasingly isolated, with
USA300-0114 being the predominant clone in the USA. Comparative whole genome sequencing of USA300 isolates
collected in 2002, 2003 and 2005 showed a limited number of single nucleotide polymorphisms and regions of difference.
This suggests that USA300 has undergone rapid clonal expansion without great genomic diversification. However, whole
genome comparison of CA-MRSA has been limited to isolates belonging to USA300. The aim of this study was to compare
the genetic repertoire of different CA-MRSA clones with that of HA-MRSA from the USA and Europe through comparative
genomic hybridization (CGH) to identify genetic clues that may explain the successful and rapid emergence of CA-MRSA.
Materials and Methods: Hierarchical clustering based on CGH of 48 MRSA isolates from the community and nosocomial
infections from Europe and the USA revealed dispersed clustering of the 19 CA-MRSA isolates. This means that these 19 CA-
MRSA isolates do not share a unique genetic make-up. Only the PVL genes were commonly present in all CA-MRSA isolates.
However, 10 genes were variably present among 14 USA300 isolates. Most of these genes were present on mobile elements.
Conclusion: The genetic variation present among the 14 USA300 isolates is remarkable considering the fact that the isolates
were recovered within one month and originated from a confined geographic area, suggesting continuous evolution of this
clone.
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Introduction
The epidemiology of methicillin-resistant Staphylococcus aureus
(MRSA) infections has changed dramatically during the last 15
years. While traditionally MRSA was a typical example of a
nosocomial pathogen, it is now frequent found as causative agent
of community-associated infections among patients without known
risk factors for hospital-acquired (HA)-MRSA [1,2,3,4,5,6,7].
The molecular epidemiology of community-associated MRSA
(CA-MRSA) is diverse, although certain clones appear to
dominate on every continent. These predominant CA-MRSA
clones cluster in different lineages: ST8/USA300, ST1/USA400,
ST30/USA1100, ST93, ST59, ST80 and ST398 clone [8].
In the USA, the first widely recognized CA-MRSA clone was
USA400 (ST1). After the turn of the century, USA300 (ST8)
emerged rapidly across the USA and replaced USA400 as the
dominant clone in the USA responsible for the majority of skin
and soft tissue infections. Subsequently, USA300 has been
increasingly isolated outside the USA indicating pandemic spread.
Within USA300 several subtypes exist of which PFGE-type
USA300-0114 predominates [9,10].
Comparative whole genome sequencing of 10 USA300 CA-
MRSA and HA-MRSA isolates collected nationwide in the USA
in 2002, 2003, and 2005 showed a limited number of single
nucleotide polymorphisms and regions of differences among
USA300 isolates, which suggests that USA300 has undergone
rapid clonal expansion without great genomic diversification [11].
So far whole genome comparisons of CA-MRSA are limited to
isolates belonging to USA300. The aim of this study was to
compare the genetic repertoire of different CA-MRSA clones with
that of HA-MRSA from the USA and Europe through
comparative genomic hybridization (CGH) to identify genetic
clues that may explain the successful and rapid emergence of CA-
MRSA [12].
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Materials and Methods
Bacterial isolates and nucleic acid extraction
Thirty nine consecutive MRSA isolates collected in 2004,
originating from hospitalized patients with serious invasive
infections admitted at Cook County Hospital (Chicago IL, USA)
were taken from a database. The isolates were phenotypically
classified with MicroScan (West Sacramento, California) as
methicillin-resistant. Twenty isolates were recovered ,48 h after
admittance from patients who did not have prior health care
exposure and were considered CA-MRSA. These isolates were
collected between the 1st and 28th of July. Nineteen isolates were
recovered (between July and October of 2004) from patients.48 h
after admission and these were classified as HA-MRSA (Table S1).
Ten HA-MRSA isolates from The Netherlands, Germany,
Belgium, and France were selected from a collection of 118 HA-
MRSA isolates present at the University Medical Center Utrecht
(UMCU) on the basis of their geographic origin, infections caused or
nasal carriage and multilocus sequence type (ST) (Table S1). In
addition, one CA-MRSA isolate, obtained in 2001 from a child that
succumbed due to necrotizing pneumonia within 48 h of hospitaliza-
tion (and without prior health care exposure) in the UMCU [13]. All
isolates were cultured overnight on tryptic soy agar with sheep blood at
37uC. DNA was extracted with a Nucleospin Tissue kit according to
manufacturer’s protocol (Bioke´, Leiden, The Netherlands). Plasmid
DNA content was determined using S1 nuclease treatment (Takara Bio
Europe, Saint-Germain-en-Laye, France), gel electrophoreses and
southern blot with a 193 bp probe from the resolvase gene SAR719.
We do not have an ethics approval and an informed consent,
because the data we have used are anonymous and were not
specifically collected for our study. The patients were admitted to the
hospital, the samples were taken for diagnostic purposes by the
treating physicians in order to appropriately treat the patients. These
samples were anonymously put in a database from which they were
recovered. In the Netherlands the Medical Ethical Committee does
not require an approval for this kind of research and sampling.
Typing of the MRSA isolates
Colony morphology and standard techniques, like multiplex
PCR for the 16S rRNA gene, mecA gene, and nuc gene were used
to confirm whether the isolates were MRSA. All MRSA isolates
from the USA were typed by MLST [14]. The CA-MRSA isolates
were further characterized by PFGE, spa, SCCmec and antimicro-
bial susceptibility patterns by MicroScan (Dade Behring Inc., West
Sacramento, CA, USA) [15,16,17]. The antimicrobial agents
tested were oxacillin, erythromycin, rifampicin, fluoroquinolones,
clindamycin, gentamicin and tetracycline. The MIC values were
interpreted according to the Clinical and Laboratory Standards
Institute recommendations (2004) [18].
Comparative genomic hybridization
Gene content of the CA- and HA-MRSA isolates was determined
via CGH using a previously described multistrain (n= 7) PCR
product S. aureusmicroarray [19,12]. The array design is available in
BmG@Sbase (Accession No. A-BUGS-17; http://bugs.sgul.ac.uk/
A-BUGS-17) and also ArrayExpress (Accession No. A-BUGS-17).
Gene presence and divergence was determined using the algorithm
described previously [20]. Complete linkage hierarchical clustering
with Euclidian distance of all the HA-MRSA and CA-MRSA
isolates was used to visualize the genetic relatedness.
Confirmation of genetic differences
Differences in gene content between the USA300 CA-MRSA
isolates from Chicago and USA300FPR3757 and USA300TC
H1516 (for which the whole genome sequences are available) as
identified by CGH were confirmed by PCR and sequencing. The
primers were generated, if possible, using the USA300FPR3757
sequence and otherwise on the USA300TCH1516 or MRSA252
sequence. Amplification was carried out for 35 cycles with
denaturation at 95uC for 30 seconds, annealing at the primer
specific annealing temperature for 30 seconds, extension at 72uC
for 45 seconds and a final extension at 72uC for 7 minutes. The
presence of arcA considered specific for SCCACME, lukS-PV and
lukF-PV, encoding Panton-Valentine leukocidin, sek and seq
encoding enterotoxin K and Q, respectively, in the USA300
strains from Chicago were determined by PCR as previously
described [9,21]. The primers and conditions used for confirma-
tion are shown in the Table S2.
Results
Molecular epidemiology of CA- and HA-MRSA
The majority of the 19 HA-MRSA isolates from the USA
belonged to ST5 (n= 14, 74%). From the five other isolates, four
were classified as ST8 and one as ST45 (Table S1).
Two of the 20 CA-MRSA isolates from the USA were mecA
negative in the PCR, and were no longer considered MRSA. From
the remaining 18 CA-MRSA isolates from the USA, 14 were
typed by PFGE as USA300 and 13 represented the USA300-0114
subtype. One isolate (S16) had a slightly different PFGE subtype
and differed by two bands (Figure 1). MLST was in agreement
with these data, since 13 USA300 strains were ST8. One isolate
(S08) represented ST858, a single locus variant of ST8 (Table 1).
All isolates, except one, belonged to spa-type t008. That isolate
(S06) had a new spa-type, t4913 (11-19-36-21-17-34-24-34-22-25),
one repeat difference with t008 (Table 1).
The other four CA-MRSA from the USA belonged to PFGE
type USA400 (ST1) (n = 1) and USA100 (ST5) (n = 3) (Table 1).
The CA-MRSA isolate from The Netherlands belonged to ST80.
The infections caused by the HA-MRSA isolates were more
diverse than the infections caused by the CA-MRSA strains (Table
S1). The patients with HA-MRSA suffered from pneumonia
(n = 7), skin and soft tissue infections (n = 7), urinary tract
infections (n = 3), sepsis (n = 8) and a bone infection (n= 1). Three
isolates came from colonized patients and were collected with
nasal swabs (Table S1). The majority of the CA-MRSA isolates
from the USA (n= 14, 78%) caused skin and soft tissue infections.
In three patients (S01, S04 and S16), the bacteria were isolated
from blood. In one other (S12) case the bacteria were isolated from
a catheter (Table 1).
Two of the 14 USA300 CA-MRSA isolates (S04 and S13) were
only resistant to b-lactam antibiotics (Table 1). The other 12 were
also resistant to erythromycin. One isolate (S16) was also resistant
to rifampicin.
Differences in gene content between CA- and HA-MRSA
Fully annotated microarray data have been deposited in
BmG@Sbase (accession number E-BUGS-108; http://bugs.sgul.
ac.uk/E-BUGS-108). Hierarchical clustering based on the CGH-
data showed no grouping of isolates based on community or
hospital origin but on the basis of their ST type, which is in
concordance with previous observations. Isolates with ST5 and -8
are split in different groups (Figure 2) [19]. The 19 CA-MRSA
isolates were dispersed among all isolates represented on the
dendogram (Figure 2). This finding indicates that the CA-MRSA
do not share a common and unique genetic repertoire. The PVL
genes were present in all CA-MRSA isolates and absent in all HA-
MRSA isolates based on the microarray data and confirmed by
Genetic Variation in USA300 Isolates
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e16419
PCR. In addition, PCR demonstrated that arcA, sek and seq were
present in all analyzed USA300 CA-MRSA.
Genomic variation among USA300 CA-MRSA
There were remarkable genetic differences between the 14
USA300 CA-MRSA isolates. A difference in gene content was not
confined to one isolate but was found in nine of the 14 isolates
(Table 2), although isolate S04 had most variation compared to the
other isolates. Furthermore, differences in plasmids were found
among the 14 isolates from the USA. Although most isolates
(n = 9, 65%) contained two plasmids of similar size (data not
shown), four isolates did not contain any plasmids (S3, S6, S15 and
S18) and one isolate (S20) had three plasmids, which were of the
same size as the plasmids of USA300FPR3757.
CGH (with PCR confirmation) indicated that nine genes were
variably present among the 14 USA300 strains (Table 2). In
Figure 1. PFGE pattern of the 14 USA300 strains. PFGE pattern clusters of 14 USA300 isolates from Chicago clustered using BioNumerics version
5.10 (Applied Maths NV, Sint-Martens-Latem, Belgium). Isolate number and ST are indicated. The left side of the banding pattern indicates the start of the
PFGE gel. Thirteen of the 14 isolates belong to PFGE type USA300-0114, only S16 showed two bands difference and belongs to a different subtype.
doi:10.1371/journal.pone.0016419.g001
Table 1. Demographic and clinical characteristics of the 18 CA-MRSA isolates from the USA based on MicroScan.
Isolate Isolation date PFGE type ST (CC) spa-type SCCmec Isolation site Resistancea
S01 07-02-2004 USA100 (subtype b) 5 t002 II Blood b,CD, L
S02 07-02-2004 USA100 (subtype a) 5 t002 II Skin/soft tissue b,CD, L
S03 07-04-2004 USA300-0114 8 t008 IV Skin/soft tissue b,E
S04 07-04-2004 USA300-0114 8 t008 IV Blood b
S05 07-03-2004 USA400 (subtype c) 1 t008 IV Skin/soft tissue b
S06 07-07-2004 USA300-0114 8 t4913 IV Skin/soft tissue b,E
S07 07-06-20 04 USA300-0114 8 t008 IV Skin/soft tissue b,E
S08 07-09-2004 USA300-0114 858 (8) t008 IV Skin/soft tissue b,E
S10 07-12-2004 USA300-0114 8 t008 IV Skin/soft tissue b,E
S11 07-16-2004 USA300-0114 8 t008 IV Skin/soft tissue b,E
S12 07-17-2004 USA100 (subtype b) 5 t002 II Cathether b,E,L
S13 07-16-2004 USA300-0114 8 t008 IV Skin/soft tissue b
S15 07-20-2004 USA300-0114 8 t008 IV Skin/soft tissue b,E
S16 07-22-2004 USA300 8 t008 IV Blood b,E,R
S17 07-24-2004 USA300-0114 8 t008 IV Skin/soft tissue b,E,T
S18 07-26-2004 USA300-0114 8 t008 IV Skin/soft tissue b,E
S19 07-28-2004 USA300-0114 8 t008 IV Skin/soft tissue b,E
S20 07-28-2004 USA300-0114 8 t008 IV Skin/soft tissue b,E,T
aResistance patterns were determined with MicroScan (Dade Behring INC. West Sacramento, CA, USA). b= b-lactam antbiotics, E = erythromycin, R = rifampicin, L =
quinolones, CD= clindamycin, G = gentamicin and T = tetracycline.
doi:10.1371/journal.pone.0016419.t001
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addition, one gene present in the sequenced USA300FPR3575
and USA300TCH1516 strains was absent in all 14 analyzed
USA300 CA-MRSA isolates. This gene (SAR2565) encodes an
exported protein (Table 2).
Seven of the in total 10 genes that were variably present or
absent in USA300 isolates, were located on known mobile genetic
elements (MGE) in the published genomes (Table 2), whereas the
three other genes were located in regions that are not considered
to be mobile. This indicates that the genes that are variably
present in USA300 are not located adjacent to each other, but
dispersed across the genome (data not shown).
The 10 genes encode for serine protease-like E protein (splE)
(SAR1902), serine protease-like C protein (splC) (SAR1906); a
resolvase (tnpR) (SAR0719), a putative DNA repair protein
(SAR0617), the exported protein gene SAR2565, a gene encoding
a membrane protein (SAR2132), two genes encoding phage
proteins (SAR1554 and SAR2066) and two genes encoding
hypothetical proteins (SAR1682 and SAR0056).
The differentially present genes splE and splC are part of a 5 kb
spl operon, encoded on genomic island nSab which is present in
most, but not in all S. aureus strains [22]. The other four genes of
the spl-operon (splA, splB, splD, and splF) were present in all
USA300 isolates analyzed by CGH.
The resolvase gene (SAR719), which is absent in isolate S04,
is located on a 26 kb plasmid (pUSA300HOUMR) in USA
300TCH1516. This was confirmed by Southern blot (data not
shown).
The membrane protein gene (SAR2132), absent in isolate S18
has 58.62% (amino acid) similarity with the hypothetical protein
YeeE in E. coli which is a putative transport system permease
protein. This gene is present in the majority of the sequenced S.
aureus strains (data not shown).
There were two genes that were differentially present and that
tentatively encode phage proteins. One of the hypothetical phage
proteins (SAR2066) is similar to the C-terminal region of
Streptococcus thermophilus bacteriophage Sfi21 hypothetical protein
and is only present in the sequenced USA300 isolates, MRSA252,
Mu3 and Newman strains. The second phage protein (SAR1554)
is 97.96% (amino acid) similar to a S. aureus prophage phiPV83
protein which is differently present in the sequenced strains
MRSA252, JH9, JH1 and S0385.
Discussion
The rapid emergence of specific MRSA clones, like USA300,
first in the community followed by dispersal in hospitals is still
largely unexplained. Our study confirmed previous findings that
all CA-MRSA clones do not share a common genetic repertoire
that is unique to these clones other than PVL toxin genes, which
are present in most USA300 isolates [23,21,24]. Despite being
ubiquitously present in our set of USA300 isolates, USA300
isolates without the PVL and SCCACME genes have been
Figure 2. Hierarchical clustering of HA and CA-MRSA from the
USA and the Netherlands. Hierarchical clustering based on Euclidean
distance with complete linkage made in TIGR MultiExperiment Viewer
version 3.1 (Dana-Farber Cancer Institute, Boston, USA). The genes are
clustered on the y-axis. On the x-axis the fifty different CA-MRSA and HA-
MRSA isolates from the USA and the Netherlands are depicted. In this
figure the conserved genes are not depicted, although they haven been
used to for clustering. The top colored line depicts the different ST-types:
pink bars: CC8, light blue bars: CC5, yellow bars: ST30, orange bar: ST80,
green bars: ST1, red bars: ST45. The second colored bar represents the
different MRSA-types: pink bars: CA-MRSA; light blue bars indicate HA-
MRSA.
doi:10.1371/journal.pone.0016419.g002
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described recently [25,26]. This could mean that PVL and
probably SCCACME have a less significant role in CA-MRSA
virulence than previously assumed.
In contrast to previously published studies by Tenover et al. and
Kennedy et al., we found an unexpected high number of genetic
differences among 13 PFGE subtype USA300-0114 clones isolated
within the time-frame of one month from a single location [11,27].
Of the genes that were differentially present among the USA300
isolates from Chicago, or even completely absent, compared to the
sequenced USA300 isolates, eight were identified for the first time as
being differentially present among CA-MRSA, thus representing
non-core CA-MRSA genes. However, it should be noted that
divergent gene orthologues that are not represented on the array,
may be present among the 14 USA300 isolates because USA300
was not used to create the microarray. Next to that the majority of
the sequenced isolates used to generate the microarray described in
this study were laboratory strains, which were collected years before
the clinical USA300 specimens were accumulated, making it even
more likely that USA300 strains and other CA-MRSA clones may
contain novel genetic elements absent in the older strains.
Non-core genes contribute significantly to the overall diversity of
gene repertoires in a species. The vertically transmitted core genome
encodes fundamental cellular processes, and the horizontally
transmissible accessory genome encodes for a variety of secondary
metabolites, resistance to specific toxins, virulence factors or
antibiotics [28]. Seven of the in total 10 genes that were variably
present or absent in USA300 isolates, were located on mobile genetic
elements (MGE) (Table 2). This was as expected, because mobile
genetic elements easily account for significant gene diversity among
strains that are closely related with respect to the core genome.
However, 3 of the 10 genes were located in regions that are not
considered to be MGEs. In addition, the genetic differences, which
are located on the MGEs involve only single genes and the isolates
did not lose or acquire a complete genetic element. But we also found
variation in the plasmid content of the 14 USA300 isolates.
From literature (Kennedy et al. and Tenover et al.) it seems that
the USA300 isolates used in these studies [11,27] were less diverse.
The majority of these isolates are collected from different
geographic regions and before 2004. This could suggest the
USA300 isolates are less genetically diverse before 2004. However,
in order to be certain about this, it will be necessary to analyze
isolates from the same hospital in Chicago before 2004.
Unfortunately we do not have these data.
Two of the variably present genes are located on the spl-operon.
The spl genes are positively controlled by agr, one of the regulators
responsible for the global regulation of virulence factors in S.
aureus, which is conserved in all staphylococcal species. The genes
are most similar to a V8 protease, which can cleave the heavy
chain of human immunoglobulin classes in vitro. In 64% of
the isolates the spl operon was present and no obvious role in
virulence was demonstrated in intraperitoneally injected rats
[22,29].
The observed genetic differences between the 14 USA300
isolates, recovered within the time-frame of one month and from a
single location, suggests continuous evolution of this clone. In fact
one may argue that following a period of intense and rapid clonal
dispersion, USA300 has now entered a period of development of a
polyclonal lineage rather than a single dispersing clone, which was
also suggested by Kennedy et al [11]. Whether the observed
differences in gene content indicate random loss or acquisition of
genes or reflect local adaptation, and whether these differences
affect virulence remains to be investigated.
Supporting Information
Table S1 Characteristics of HA-MRSA isolates used in
this study.a Sequence type (ST) with clonal complex between
brackets.
(DOC)
Table S2 PCR primers used to validate the 10 genetic
differences. a MRSA252 ORF: MRSA252 open reading frame
is the MRSA252 gene-number, which corresponds with the
specific gene.
(DOC)
Table 2. Genetic differences between the 14 USA300 isolates based on comparative genomic hybridization data and PCR.
Gene
MRSA252
(ORF) Location Results for
S3 S4 S6 S7 S8 S10 S11 S13 S15 S16 S17 S18 S19 S20
USA300
TCH1516
USA300
FPR3757
DNA repair protein SAR0617 MGE + + + + + + + + + + - + + + + +
Resolvase SAR0719 MGE + - + + + + + + + + + + + + - +
Serine protease-like C SAR1906 Chromosome - + - + + + - + + + + + + + + +
Serine protease-like E SAR1902 Chromosome - + + + + + + + + + + + + + + +
Membrane protein SAR2132 MGE + + + + + + + + + + + - + + + +
Hypothetical protein SAR1682 MGE + - + + + + + + + + + + + + - -
Phage protein SAR1554 MGE - + - - - - - - - - - - - - + +
Phage protein SAR2066 MGE + + + + + + + - + + + + + + + +
Exported protein (PCR)a SAR2565 Chromosome + - + + + + + + - + + + + + - -
Exported protein
(microarray)b
SAR2565 Chromosome NRc - NR NR NR + NR NR NR NR NR - + - - -
Hypothetical protein SAR0056 MGE + + + + + + + + + + + + + - + +
aThe results of the Exported gene (SAR2565) in the confirmation PCR, of which the primers are shown in Table S2.
bThe results of the Exported gene (SAR2565) gained by the hybridization of the 14 USA300 isolates on the microarray earlier described.
cNR: not reliable.
doi:10.1371/journal.pone.0016419.t002
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